Company orders expansion of product recall. The maker of a skin patch used to treat pain is voluntarily recalling its product.
Janssen Pharmaceutica Products, L.P., is expanding its U.S. recall of the Duragesic pain patch to include five lots of the product.
The patches are coated with an opiate gel, and the manufacturer says some of the patches may leak, causing patients to get too much or too little medication.
The leak could lead to an overdose or withdrawal symptoms.
Anyone who has 75 mcg/hour DURAGESIC patches should examine the control number
Anyone who has 75 mcg/hour DURAGESIC patches should examine the control number that appears on the bottom flap of the outer carton or back of the foil pouch.
Those who have patches from lots with control numbers 0327192, 0327193, 0327294, 0327295, and 0330362 must contact their physician or pharmacist immediately for specific instructions on returning patches from recalled lots and obtaining a new supply.
Patients wearing other dosage strengths or Duragesic patches that are not from the recalled lots can continue to wear them. Sudden discontinuation of Duragesic can cause serious health problems.
Need Legal Help Regarding Pain Skin Patch?
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).
